BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27742544)

  • 1. Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
    Stienne C; Michieletto MF; Benamar M; Carrié N; Bernard I; Nguyen XH; Lippi Y; Duguet F; Liblau RS; Hedrick SM; Saoudi A; Dejean AS
    Immunity; 2016 Oct; 45(4):774-787. PubMed ID: 27742544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
    Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
    J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis.
    Yeh WI; McWilliams IL; Harrington LE
    J Immunol; 2011 Nov; 187(10):4998-5006. PubMed ID: 21984703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
    Codarri L; Gyülvészi G; Tosevski V; Hesske L; Fontana A; Magnenat L; Suter T; Becher B
    Nat Immunol; 2011 Jun; 12(6):560-7. PubMed ID: 21516112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct GM-CSF
    Rasouli J; Casella G; Yoshimura S; Zhang W; Xiao D; Garifallou J; Gonzalez MV; Wiedeman A; Kus A; Mari ER; Fortina P; Hakonarson H; Long SA; Zhang GX; Ciric B; Rostami A
    Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33097590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
    O'Connor RA; Cambrook H; Huettner K; Anderton SM
    Eur J Immunol; 2013 Nov; 43(11):2818-23. PubMed ID: 23878019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation.
    Sheng W; Yang F; Zhou Y; Yang H; Low PY; Kemeny DM; Tan P; Moh A; Kaplan MH; Zhang Y; Fu XY
    Cell Res; 2014 Dec; 24(12):1387-402. PubMed ID: 25412660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.
    Bettelli E; Sullivan B; Szabo SJ; Sobel RA; Glimcher LH; Kuchroo VK
    J Exp Med; 2004 Jul; 200(1):79-87. PubMed ID: 15238607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
    Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
    PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eomes expression reports the progressive differentiation of IFN-γ-producing Th1-like γδ T cells.
    Lino CNR; Barros-Martins J; Oberdörfer L; Walzer T; Prinz I
    Eur J Immunol; 2017 Jun; 47(6):970-981. PubMed ID: 28386934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD4 T cells.
    Suzuki J; Maruyama S; Tamauchi H; Kuwahara M; Horiuchi M; Mizuki M; Ochi M; Sawasaki T; Zhu J; Yasukawa M; Yamashita M
    Immunology; 2016 Apr; 147(4):476-87. PubMed ID: 26749286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23.
    Grifka-Walk HM; Giles DA; Segal BM
    Eur J Immunol; 2015 Oct; 45(10):2780-6. PubMed ID: 26220255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.
    Ariga H; Shimohakamada Y; Nakada M; Tokunaga T; Kikuchi T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2007 Oct; 122(2):210-21. PubMed ID: 17490433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis.
    Othy S; Hegde P; Topçu S; Sharma M; Maddur MS; Lacroix-Desmazes S; Bayry J; Kaveri SV
    J Immunol; 2013 May; 190(9):4535-41. PubMed ID: 23526819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression.
    Suto A; Wurster AL; Reiner SL; Grusby MJ
    J Immunol; 2006 Sep; 177(6):3721-7. PubMed ID: 16951332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination.
    Thieu VT; Yu Q; Chang HC; Yeh N; Nguyen ET; Sehra S; Kaplan MH
    Immunity; 2008 Nov; 29(5):679-90. PubMed ID: 18993086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
    Sinha S; Miller LM; Subramanian S; Burrows GG; Vandenbark AA; Offner H
    PLoS One; 2011; 6(7):e21868. PubMed ID: 21750737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation.
    Zhang C; Raveney BJE; Hohjoh H; Tomi C; Oki S; Yamamura T
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21131-21139. PubMed ID: 31570595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E; Irony-Tur-Sinai M; Lory O; Orr-Urtreger A; Lavi E; Brenner T
    J Immunol; 2009 Nov; 183(10):6681-8. PubMed ID: 19846875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.